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The structural requirements for L-selectin shedding were studied in murine leukocytes. Upon
activation, L-selectin on both lymphocytes and neutrophils undergoes cleavage by a mem-
brane metalloprotease, resulting in the generation of a soluble ectodomain and a mem-
brane-retained 6 kD fragment. Radiochemical sequencing demonstrated a cleavage site in the
membrane-proximal region (MPR) between R321 and $322, which is homologous to the
human site. Although intact neutrophil L-selectin is larger, it is cleaved at the same, or very
close, site. Analysis of several transfectants expressing L-selectin point mutations and chi-
meric constructs suggest that, like human shedding, the proteolytic process has relatively
loose sequence specificity for the substrate site. In addition, some constructs are susceptible
to slow constitutive cleavage, but their shedding does not increase upon PMA stimulation,
showing that basal and activated shedding are separable processes. Insertion of the 15 amino
acid MPR into murine B7.2 conferred upon this molecule susceptibility to constitutive shed-
ding. PMA stimulation results in little or no acceleration of down regulation of this molecule.
These results suggest that recognition of both the membrane-proximal cleavage site and of a
site distant from the MPR are required for maximal induction of L-selectin shedding.
Keywords: intercellular adhesion, L-selectin, metalloprotease, shedding
Abbreviations: LN, lymph node, HEV, high endothelial venule, MPR, membrane-proximal region, MRF,
membrane-retained fragment
INTRODUCTION
The adhesion molecule L-selectin expressed on the
surface of B and T lymphocytes mediates the initial
interaction of lymphocytes with high endothelial
venules (HEV) in the T-dependent zone of lymph
nodes (LN). Lymphocytes require L-selectin to home
to LN and this molecule therefore is a central regula-
tor of lymphocyte recirculation in vivo. Thus, lym-
phocytes from genetically L-selectin-deficient mice
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are completely unable to home from the bloodstream
into LN, the LN are systemically atrophic, and
immune responses to peripherally located antigens
are therefore suppressed or delayed (Arbones et al.,
1994; Catalina et al., 1996; Steeber et al., 1996; Ted-
der et al., 1995; Xu et al., 1996). The expression of
L-selectin is regulated at a series of steps, including
modulation of transcription, mRNA stability, and
post-translationally at the cell surface (Chao et al.,
1997). Post-translational regulation of L-selectin is268 LI-CHAO ZHAO et al.
much more rapid than regulation at the other steps
and involves rapid proteolytic cleavage and shedding
of the membrane molecule (Huang et al., 1990; Jung
and Dailey, 1990). A similar mechanism causes
L-selectin down regulation in neutrophils (Jutila et
al., 1990; Kishimoto et al., 1989). Lymphocyte
L-selectin shedding is induced upon treatment with
PMA (Jung and Dailey, 1990), calmodulin antago-
nists (Kahn et al., 1998), or after cross-linking CD3
with antibody (Chao et al., 1997), suggesting possible
roles of PKC and calcium-calmodulin-dependent
kinases in regulating shedding. While the precise
function of L-selectin shedding is as yet unclear, it
may have a role in regulating transendothelial migra-
tion of lymphocytes and some evidence shows that it
may affect leukocyte rolling on endothelium
(Hafezi-Moghadam and Ley, 1999; Walcheck et al.,
1996).
The protease responsible for L-selectin shedding
has been shown to be a novel integral membrane
Zn+/-dependent metalloprotease on the surface of the
cell (Black et al., 1997; Moss et al., 1997). Upon acti-
vation, this enzyme recognizes L-selectin and then
cleaves it just external to the plasma membrane. The
same enzyme appears to be responsible for the shed-
ding of several other membrane proteins, from a vari-
ety of cell types, including TNF-c, p75TNFR,
proTGFc, and -amyloid precursor protein (Bux-
baum et al., 1998; Peschon et al., 1998). One curious
feature of this process is that it has very loose sub-
strate specificity, such that variations in amino acid
sequence in and adjacent to the cleavage sites do not
effectively block proteolysis (Hooper et al., 1997).
Thus, most mutations in the membrane-proximal
region (MPR) do not prevent the shedding of human
L-selectin (Chen et al., 1995; Migaki et al., 1995).
This enzymatic process, however, cannot be com-
pletely promiscuous because most cell surface pro-
teins are not cleaved. It is therefore unclear how this
L-selectin sheddase recognizes L-selectin or the other
proteins upon which it acts.
In the experiments reported herein, we examined
L-selectin shedding from normal mouse lymphocytes,
determined the cleavage site, and compared it to
cleavage in neutrophils. Several mutant L-selectin
transfectants were then used to examine the specifi-
city of the murine cleavage process and the mecha-
nism by which this cleavage is recognized. The data
show that murine L-selectin is cleaved at a site
homologous to its human counterpart. In addition, the
slow constitutive shedding and rapid shedding in acti-
vated cells are separable processes. While presence of
the short MPR sequence is sufficient for the basal
level of cleavage, it is not sufficient to confer upon a
heterologous protein maximal susceptibility to
PMA-induced shedding. This implies that a region of
L-selectin distant from the MPR is recognized by the
protease, or a protease-associated molecule, and that
this recognition is important in the normal enzymatic
cleavage of L-selectin in PMA-stimulated cells.
MATERIALS AND METHODS
Cell Culture and Antibodies
An L-selectin-negative clone of the mouse T lym-
phoma cell line, TK-1, was maintained in RPMI 1640
supplemented with 10% FCS, penicillin (1,000 U/ml),
streptomycin (1,000 U/ml), glutamine (20 mM),
HEPES (10 mM) and 2-mercaptoethanol (50 tM). The
stable transfectant lines were maintained in the com-
plete medium containing 0.5 mg/ml G418 (Calbio-
chem, La Jolla, CA). The following antibodies were
used in this study: MEL-14: rat IgG2a anti-mouse
L-selectin; T28: mouse IgG2 anti-mouse L-selectin of
Ly22
/ allotype; GL-I: rat IgG2a anti-mouse B7.2.
These mAbs were prepared from tissue culture super-
natant and used conjugated to biotin or phycoerythrin
(PE) using established methods (Mobley and Dailey,
1992). PE-labeled streptavidin and PE-conjugated don-
key anti-rat Ig antibody were purchased from Southern
Biotechnology Associates, Inc. (Birmingham, AL).
Neutrophil Preparation
Bone marrow cells from Balb/c mice were underlayed
with 50% Percoll (Sigma, St. Louis, MO) and then
centrifuged at 2,600 rpm for 30 min. Cell pellets wereL-SELECTIN SHEDDING 269
washed and resuspended in HBSS. Then, cells were
further separated on 63% Percoll as above. The cell
pellet was washed and the purity of neutrophils was
evaluated by Wright staining.
cDNA Constructs and Site-Specific Mutagenesis
Site-specific mutations and chimeric molecules were
generated by the sequential PCR method (Saiki et al.,
1988). Briefly, mutations were introduced using two
inner complementary primers coding for the new
amino acids. For the first PCR step, individual outer
primers that are complementary to either the upstream
sequence or downstream sequence were used with
individual inner primers to amplify a DNA fragment
from the template. Then the two amplified fragments
were annealed and used as a template for the second
PCR reaction, in which only the two outer primers
were used. The final mutated PCR products were
digested with appropriate enzymes and used to
replace the equivalent DNA fragment in the original
wt cDNA construct.
L-selectin cDNA ih the Rsv.Sneo vector, into
which mutated fragments were inserted, had the wt
sequence of the Ly22- allotype. The DNA fragment
from Apa I to BamH I was amplified in the sequential
PCR reactions to generate L-selectin mutants. Wild
type L-selectin and all L-selectin mutant cDNAs with
the Ly22- allotype were removed with Sal I and
BamH I digestion and ligated into the priSE vector
(Pitcher et al., 1989; kindly provided by Dr. D. Rau-
let) digested with the same enzymes. The sequence of
all L-selectin mutants was verified by DNA sequenc-
ing.
A chimeric molecule with the MPR of L-selectin
inserted between the extracellular and transmembrane
domains of the mouse B7.2 molecule were also gener-
ated using the sequential PCR method as follows.
First, the sequence encoding the FLAG octapeptide
(N-DYKDDDDK-C) was added to the carboxy termi-
nus of B7.2 by amplifying the EcoR V to Xba I frag-
ment of B7.2 cDNA in pCDNA3 vector with a
downstream primer containing this FLAG sequence
in a single step PCR reaction. Then this flag-tagged
B7.2 cDNA was used as a template to generate the
chimeric cDNA. A DNA fragment encoding the MPR
of L-selectin was inserted between the transmem-
brane domain and extracellular domain of B7.2 by
amplifying the EcoR V to Xba I fragment of
flag-tagged B7.2 cDNA to generate the B7.2/MPR
chimeric cDNA. B7.2 and B7.2/MPR cDNAs were
removed from pCDNA3 by Apa I and Kpn I digestion
and blunt-ended. They were then ligated into the
priSE vector digested with Sma I and EcoR V.
Stable Transfection
DNA fragments between the BssH II sites, which
contains the cDNA encoding Ly22- wt L-selectin,
L-selectin mutants and the chimeric molecules, were
removed from the priSE constructs and purified by
gel extraction. The pCDNA3 vector containing the
G418 resistance marker was linearized by Sca I diges-
tion. 10 tg of the DNA fragments containing these
cDNAs were mixed with linearized pCDNA3 vector
at a molar ratio 5:1 and were transferred to 0.5 ml
L-selectin-negative TK-1 cell suspension at 1 107
cells/ml in complete medium. The cell suspension
with the DNA constructs in a 0.4 cm electrode gap
cuvette was electroporated at 250 V, 960 tF at room
temperature using a Gene Pulser (Bio-Rad Laborato-
ries, CA). The cells were resuspended and grown in
complete medium for two days. They were then
cloned and selected at 5000 cells/well in 96-well
plates in complete medium containing 2 mg/ml G418.
Ten to 20 clones from each transfection were tested
by flow cytometry analysis with PE-conjugated
MEL-14 or GL-1 followed by PE-conjugated goat
anti-rat Ig antibodies for L-selectin or B7.2 expres-
sion, respectively. The clones positive for L-selectin
mutants were also tested for their Ly22 allotype, to
ensure that endogenous wt L-selectin genes were not
expressed, by staining the cells with biotin-conju-
gated T28 antibodies followed by PE-conjugated avi-
din. Three clones positive for MEL-14 or GL-1, but
negative for T28, were used in the following studies.270 LI-CHAO ZHAO et al.
Flow Cytometric Analysis of Cell Surface Protein
Shedding
Cells (5x 105) were resuspended in 0.5 ml Hank’s bal-
anced salt solution (HBSS) containing 10% horse
serum (FACS buffer) in test tubes. For testing
PMA-induced shedding, 100 ng/ml PMA was added to
the tubes and the cell suspension was incubated at 37C
for the time indicated. For testing the effect of the met-
alloprotease inhibitor (RO31-9790, kindly provided by
Dr. Ann Ager, London) on PMA-induced shedding of
L-selectin mutants, 50 tM RO31-9790 was added to
the tubes and the cell suspension was pre-incubated at
room temperature for 20 min. Then, 100 ng/ml PMA
was added and the cell suspension was further incu-
bated at 37C for 30 min. For all experiments, tubes
with the same concentration of DMSO added as the
experimental tubes were used as controls. Then the
cells were wash once and stained with PE-conjugated
MEL-14 antibody for L-selectin, or with GL-1 fol-
lowed by PE-coupled goat anti-rat Ig antibody for
B7.2. PE-conjugated normal rat Ig and iso-
type-matched antibody were used as negative controls.
The stained cells were analyzed on a FACS Vantage
(Becton-Dickinson, M6untain View, CA).
Preparation of Anti-Peptide Antibodies
A 17-mer oligopeptide corresponding to the cytoplas-
mic domain of mouse L-selectin (NH2-RRLKKG-
KKSQERMDDPY-COOH) conjugated to diphtheria
toxoid (Chiron Mimetopes, Australia) was used to
immunize rabbits. Antibodies were purified by pass-
ing the resulting antisera over a column containing
the cytoplasmic domain peptide.
Western Blot Analysis of L-selectin Shedding
Normal lymphocytes, neutrophils, or the transfected
TK-1 cells were left unstimulated or stimulated with
100 ng/ml PMA at 37C for the times indicated.
Depending on the expression level of L-selectin, 1 x
107 normal lymphocytes or 2 to 4 x 107 transfectants
were lysed in 1 ml lysis buffer (2% Triton X-100,
PBS, 0.1% azide and 5 mg/ml aprotinin, 2.5 mg/ml
pepstatin, 5 mg/ml leupeptin, 10 mM iodoacetamide,
2 mM PMSF, 2 mM EDTA as protease inhibitors).
Nuclei and cell debris were removed by centrifuga-
tion at 20,800xg for 30 min. at 4C. Then 100 gl 10%
sodium deoxycholate and 10 gl 10% SDS were added
to the clarified lysates at final concentrations of 1%
and 0.1%, respectively. The lysates were precleared
twice with 20 tl non-immune rabbit IgG-sepharose
beads (3 mg antibody/ml beads), followed by immu-
noprecipitation with 10 tl sepharose beads coupled
with the anti-L-selectin cytoplasmic domain peptide
antibody (1 mg antibody/ml beads) for 2 h at 4C.
Immunocomplexes were washed twice in the lysis
buffer and twice in PBS containing 0.1% Triton
X-100. The bound antigen was eluted in 25 or 45 tl
of low-pH elution buffer (100 mM glycine pH 2.5,
0.15 M NaC1, 0.1% Triton X-100) for 1 h at 4C.
Then 20 or 40 gl of eluant was collected and neutral-
ized with 2 or 4 tl of neutralization buffer (2 M
Tris-C1 pH7.4). 15 gl of the eluant was loaded on
10%-20% Tricine-SDS gels (Novex, San Diego, CA)
and separated under reducing conditions. Proteins
separated on the gel were electrotransferred to a 9 cm
x 11 cm Protran nitrocellulose membrane (Schleicher
and Schuell, Keene, NH) at 25 V overnight. The
membrane was blocked with 5% non-fat dry milk for
1 h, then was washed with TTBS (50 mM Tris-HC1
pH 7.4, 0.15 M NaC1, 0.1% Tween-20, 0.1% azide).
After washing, the membrane was incubated with 5
tg/ml anti-L-selectin cytoplasmic domain peptide
antibody in 40 ml blotting buffer (TTBS containing
1% Gelatin) for 2 h, followed by 1:40,000 horseradish
peroxidase-coupled donkey anti-rabbit Ig conjugate
(Jackson ImmunoResearch Laboratories, West Grove,
PA) in 40 ml blotting buffer. The membrane was
washed twice with TTBS for 10 min after each step.
The membranes were visualized by LumiGLO
Chemiluminescent Substrate (Kirkegaard and Perry
Laboratories, Gaithersburg, Maryland) and exposure
to film.
Radiochemical Sequence Analysis
Radiolabeled membrane-retained L-selectin cleavage
fragment was purified on a 2D gel and thenL-SELECTIN SHEDDING 271
sequenced, as described below. 1.3 x 109 Balb/c
spleen cells treated with 100 ng/ml PMA at 37C for
15 min were resuspended at 1 x 108 cells/ml in the
lysis buffer used in the western blot analysis. Cell
lysate was precleared twice with 150 tl non-immune
rabbit IgG-Sepharose beads and then immunoprecipi-
tated with 80 tl of Sepharose beads coupled with the
anti-L-selectin cytoplasmic domain peptide antibody.
The beads were washed three times with PBS con-
taining 2% Triton X-100 and 0.5% SDS, then once
with PBS containing 0.1% Triton X-100. Bound anti-
gen was eluted with 450 tl low-pH elution buffer.
The eluted protein was labeled with 1.5 mCi 1251
(Amersham Corp., Arlington Heights, IL) using
IODO-GEN (Pierce, Rockford, IL) as per the manu-
facturer’s recommendations. After labeling, proteins
were precipitated and washed twice with cold 10%
trichloroacetic acid, washed twice with acetone, and
the dried material resuspended in isoelectric-focusing
(IEF) gel sample buffer. Proteins were first separated
on an IEF tube gel (pH 3 to 10) and then separated in
the second dimension on a 10%-20% Tricine-SDS
PAGE gel (Integrated Separation Systems, Natic,
MA). Proteins on this gel were transferred to a
Westran PVDF memlrane (Schleicher and Schuell,
Keene, NH). Air-dried membrane was exposed to
Kodak XAR5 film. After the film was developed, it
was aligned with the membrane and the area corre-
sponding to the radioactive spot of the 6 kD mem-
brane-retained fragment (MRF) shown on the film
was excised from the membrane. The labeled MRF
was sequenced by automated Edmann degradation in
the University of Iowa Protein Core Laboratory. In
preliminary experiments, the identity of the
125I-labeled L-selectin MRF was confirmed by west-
ern blotting the radiolabeled material as described
above (data not shown).
RESULTS
Treatment of lymphocytes with phorbol esters that
activate PKC causes L-selectin shedding from the cell
surface. Figure la shows the decrease in selectin
expression that occurs when mouse lymph node cells
are treated with PMA, with 96% loss in 30 minutes.
Pre-treatment of the cells with RO-319790, a metallo-
protease inhibitor (Preece et al., 1996), blocks this
down regulation, confirming that this is mediated by
the selectin sheddase. PMA-treated and untreated
cells were immunoprecipitated with polyclonal anti-
body specific for the cytoplasmic domain of L-selec-
tin and then examined by western blot analysis,
blotting the membrane with the same antibody
(Figure lb). In untreated cells, there is a 95 kD band
corresponding to intact L-selectin. In addition, there
is a 6 kD band which represents the protein fragment
that remains in the membrane after release of the sol-
uble ectodomain. This consists of the cytoplasmic and
transmembrane domains and that portion of the ecto-
domain that is proximal to the cleavage site. After
PMA treatment, the gp95 band decreases in intensity,
as expected, while that of the membrane-retained
fragment increases, reflecting its generation during
proteolytic cleavage.
PMA also induces the rapid down regulation of
L-selectin in murine neutrophils, as shown in
Figure 2a. The intact molecule expressed on neu-
trophils has a higher molecular weight than that on
lymphocytes, reflecting different glycosylation
(Figure 2b; see also Kishimoto et al., 1989). Cleavage
of this molecule results in generation of the same size
MRF as with lymphocytes, demonstrating that they
are cleaved at the same, or very close, sites on the
intact molecule.
The human L-selectin cleavage site has been deter-
mined in transfectant cell lines. We performed experi-
ments to determine the precise cleavage site of the
mouse protein in normal lymphoid cells. We were
unable to internally label normal spleen cells with
radioactive amino acids to a sufficient specific activ-
ity to perform protein sequencing, so the following
approach was used. Normal spleen cells were treated
with PMA to induce shedding and membrane lysates
were immunoprecipitated with anti-cytoplasmic pep-
tide antibody. Then, the resulting immunoprecipitated
protein was labeled with 1251 and separated on a 2D
gel (Figure 3a). This resulted in a highly purified
sample of radiolabeled membrane-retained 6kD frag-
ment, which was then subjected to Edmann degrada-272 LI-CHAO ZHAO et al.
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FIGURE Shedding of L-selectin on normal lymphocytes.
(a) FACS analysis of L-selectin expression on lymph node lympho-
cytes; untreated (solid line), PMA-treated (dashed line), or
PMA-stimulated preceded by pre-treatment with the protease
inhibitor RO31-9790 (dotted line). Negative control staining with
normal rat Ig is shown in the shaded histogram. (b) Western blot
analysis of lymphocytes immunoprecipitated and detected with the
anti-cytoplasmic domain antibody. Lane 1, non-immune rabbit Ig
negative control; lane 2, untreated lymphocytes; lane 3,
PMA-treated for 10 minutes prior to lysis
P Treatment (min)
FIGURE 2 Shedding of L-selectin on neutrophils. (a) Purified neu-
trophils from bone marrow were left untreated (solid line) or
treated with PMA for 15 min. (dashed line). Shaded histogram,
negative control staining with PE-coupled normal rat Ig. (b) West-
ern blot analysis of L-selectin shedding on neutrophils. Neutrophils
or normal spleen lymphocytes were left untreated or treated with
PMA for 5 min, as indicated. Cells were lysed and analyzed as
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FIGURE 3 Determination of the cleavage site of murine L-selectin
by radiochemical sequencing. (a) 2-D gel analysis of the immuno-
precipitated, 125I-labeled membrane-retained fragment of L-selec-
tin used for sequencing. (b) Results of MRF sequencing. The plot
125 shows the -I radioactivity of each fraction obtained from the
automated sequencer. (c) Diagram of the cleavage site as deter-
mined by the position of the radioactive peak corresponding to the
labeled tyrosine residue in the MRF. The position of the labeled
tyrosine is marked by*. The end of the second SCR domain and
beginning of the transmembrane domain are indicated
tion in a protein sequencer. The 125I radioactivity was
then measured in each fraction. As shown in
Figure 3b, there is a peak of radioactivity at position
10. Comparing this to the known sequence of L-selec-
tin, and counting back from the labeled tyrosine, these
data show that the cleavage site is between R321 and
$322 (Figure 3c). This is the same site as the human
homologue, which cleaves between K283 and $284
(Kahn et al., 1994).
In order to examine how the protease recognizes its
substrate, we examined the cleavage of several
site-specific mutants and chimeric molecules. Using
the sequence information above, mutations in the
amino acids adjacent to the cleavage site were con-
structed and expressed in the murine cell line TK-1.
As shown in Figure 4, wildtype L-selectin transfect-
ants shed in response to PMA, and this shedding is
inhibited by RO-319790. The mutants with amino
acid substitutions of R321I and $322I are also shed
after PMA treatment, in keeping with the loose sub-
strate specificity shown for the human molecule
(Chen et al., 1995; Migaki et al., 1995). In contrast to
these mutations, replacement of the phenylalanine
with a proline (F323P) dramatically inhibits
PMA-induced down regulation; even after 30 min-
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FIGURE 4 FACS analysis of PMA-induced shedding of point
mutants of L-selectin. TK-1 cells transfected with cDNA of wt
L-selectin, R321I, $322I, F323P were treated with PMA, with or
without protease inhibitor, and then analyzed as described in







FIGURE 5 Western blot analysis of preteolytic cleavage of the pro-
line substitution mutant. Untreated or PMA-treated F323P mutant
transfectant was immunoprecipitated and probed as described in
Materials and Methods. Similar analysis performed on wildtype
and mock-transfected cells are shown for comparison
Western blot analy,sis shows that the wildtype
L-selectin transfectant expresses the normal gp95
band, which down regulates upon stimulation, and the
same 6 kD MRF as seen in normal lymphocytes
(Figure 5). Surprising results, however, were obtained
with the F323P mutant. Western blots of F323P show
a dark gp95 band, as expected, but also show consid-
erable amount of the 6 kD MRE Treatment withPMA
neither induces a decrease in gp95 or any change in
the MRE Thus, while shedding of this molecule does
not increase with PMA stimulation, it is subject to an
invariant basal level of proteolytic cleavage.
The simplest structural unit that might be recog-
nized by the protease is, of course, the region around
the cleavage site itself, although that recognition
would have to be relatively relaxed. In order to deter-
mine whether the MPR by itself is sufficient for rec-
ognition, a chimeric cDNA was constructed in which
the MPR was inserted into the membrane-proximal
sequence of murine B7.2. Transfectants expressing
the B7.2/MPR chimera or wildtype B7.2 were treated







FIGURE 6 Constitutive shedding of B7.2 containing the MPR of
L-selectin. (a) TK-1 cells transfected with wt B7.2 and B7.2/MPR
chimeric cDNA (as indicated) were treated with PMA and stained
with anti-B7.2. (b) B7.2 and B7.2/MPR transfectants were incu-
bated in RO31-9790 (dotted line) for 2h, followed by flow cyto-
metric analysis with anti-B7.2. The solid line shows the
fluorescence of cells treated with the inhibitor solvent, DMSO,
only
determined by immunofluorescence analysis with
anti-B7.2 antibody. As shown in Figure 6a, both con-
structs are expressed well. B7.2 is not down regulated
in response to PMA treatment, as expected. In multi-
ple experiments, the level of B7.2/MPR down regula-
tion varied from 0 to 25% (mean 8%). This suggests
that that presence of the MPR is not sufficient to
make a membrane protein undergo efficient
PMA-induced shedding.
Indirect evidence for basal cleavage of the
B7.2/MPR chimera, however, is shown in Figure 6b.
B7.2 and B7.2/MPR transfectants were incubated in
fresh medium in the absence or presence of the pro-
tease inhibitor. Two hours later, the cells were stained
with anti-B7.2 antibody for FACS analysis. The
expression of the wildtype B7.2 molecule did not
change over time. In contrast, B7.2 fluorescenceL-SELECTIN SHEDDING 275
increased in the cells expressing the B7.2/MPR chi-
mera (1.7-fold increase in mean fluorescence inten-
sity). This suggests that the B7.2 molecule expressing
the membrane-proximal sequence of L-selectin
undergoes basal shedding, and that blocking the pro-
tease thereby increases its level of expression on the
cell surface. Similar treatment of the wt L-selectin
transfectant with the protease inhibitor resulted in an
increase in fluorescence intensity of 40% (data not
shown). This smaller increase is probably due to a
slower rate of synthesis of this molecule.
DISCUSSION
There is an ever lengthening list of cell surface pro-
teins whose expression is regulated by endoproteo-
lytic cleavage (Hooper et al., 1997). This release
sometimes generates a soluble molecule with impor-
tant biological activity, as is the case for the shedding
of membrane-associated TNF-t and proTGF-c
(Peschon et al., 1998). Indeed, the soluble ectodo-
main of L-selectin retains ligand-binding activity
(Dailey, 1993), and t has been proposed that this
might regulate the interaction of lymphocytes with
endothelium (Schleiffenbaum et al., 1992). The shed-
ding of L-selectin is particularly remarkable because
of its rapidity and its near completeness. Analysis of
the specificity of human L-selectin cleavage using
transfected cell lines demonstrated a cleavage site
eleven amino acids external to the cell membrane and
showed further that extensive amino acid substitution
within the surrounding amino acids has little effect on
shedding (Kahn et al., 1994; Migaki et al., 1995). In
the current report, we determined the cleavage site of
murine L-selectin and did so using normal lym-
phocytes, not cell lines. The results showed that
cleavage occurs between R321 and $322, a site that is
homologous to that of the human molecule. Again
like human L-selectin, our analysis of mutations adja-
cent to the cleavage site demonstrated limited
sequence specificity.
Our previous demonstration of shed antigen in the
supernatant of normal lymphocytes showed that the
normal turnover of L-selectin occurs through slow
constitutive shedding (Jung and Dailey, 1990). Thus,
addition of PMA or treatment of T cells with
anti-CD3 results in a dramatically increased rate of
cleavage (Chao et al., 1997; Jung and Dailey, 1990).
Interestingly, the point mutation phenylalanine to pro-
line in the MPR (F323P), which would induce a
marked change in tertiary structure, does not inhibit
constitutive cleavage, but it completely blocks the
ability of the cells to up regulate cleavage in response
to PMA. Thus, basal and activated shedding are sepa-
rable processes. While the basal shedding represents
the mechanism of normal selectin turnover, rapid
shedding may be the correlate of events occurring
during the interaction of lymphocytes with HEV
endothelial cells, perhaps facilitating transition to
firm adhesion or allowing for de-adhesion after
undergoing transendothelial migration.
Since most cell surface proteins are not shed after
PKC activation, the proteolytic machinery must have
considerable substrate specificity, even if that specifi-
city is not defined by the primary structure at and
around the cleavage site. This raises the question of
how this recognition takes place. The results suggest-
ing that the B7.2/MPR chimeric molecule undergoes
basal shedding and very inefficient PMA-induced
shedding implies that the MPR by itself is sufficient
to render a protein susceptible to metalloproteolytic
cleavage in the cell membrane. This is consistent with
the finding that a chimeric construct with the MPR,
transmembrane region and cytoplasmic tail of
L-selectin attached to alkaline phosphatase can be
cleaved by the enzyme on cell membranes (Feehan et
al., 1996).
Basal proteolytic cleavage, which proceeds nor-
mally in the F323P proline substitution mutant, has
less stringent recognition requirements than the
PMA-stimulated rapid cleavage. The poor PMA
inducibility of cleavage of the B7.2/MPR chimera
suggests that a region distant from the substrate cleav-
age site must be recognized during the activated shed-
ding process, probably by the protease itself. In intact
L-selectin, one possibility for this remote recognition
site is the EGF domain, which could be a docking site
for the protease, as has been suggested previously
(Dailey, 1993). EGF-like sequences expressed else-276 LI-CHAO ZHAO et al.
where regulate protein-protein interactions and the
activity of other proteases (Campbell and Bork,
1993). The interaction of the protease with the MPR
of L-selectin is weaker than that with the substrate
site of TNFt (Peschon et al., 1998). It is therefore
possible that, upon activation of proteolysis, a portion
of the enzyme recognizes the EGF domain, increasing
the overall affinity of the interaction and increasing
the rate of cleavage at the separate active site. The
nature of the process responsible for activating prote-
olysis is completely unknown, and could involve
changes (e.g., phosphorylation) of the protease itself,
of a protease-associated molecule, or a topological
change in L-selectin that exposes the putative recog-
nition site in the EGF domain. The inability of the
F323P mutant to down regulate in response to PMA
could reflect the inability of this molecule to undergo
the conformational change required for increased sus-
ceptibility to proteolytic attack.
Proteolytic shedding results in a rapid loss of cell
surface L-selectin, which must have a dramatic influ-
ence on leukocyte migration. It remains to be deter-
mined how L-selectin and other plasma membrane
substrates are recognized by this enzyme, how the
process is regulated, and the physiologic role of this
cleavage in L-selectin-mediated cell traffic in vivo.
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